Glycosaminoglycans and Proteoglycans

In this editorial to MDPI Pharmaceuticals special issue “Glycosaminoglycans and Proteoglycans” we describe in outline the common structural features of glycosaminoglycans and the characteristics of proteoglycans, including the intracellular proteoglycan, serglycin, cell-surface proteoglycans, like s...

Descripción completa

Detalles Bibliográficos
Autores principales: Pomin, Vitor H., Mulloy, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874723/
https://www.ncbi.nlm.nih.gov/pubmed/29495527
http://dx.doi.org/10.3390/ph11010027
_version_ 1783310218521739264
author Pomin, Vitor H.
Mulloy, Barbara
author_facet Pomin, Vitor H.
Mulloy, Barbara
author_sort Pomin, Vitor H.
collection PubMed
description In this editorial to MDPI Pharmaceuticals special issue “Glycosaminoglycans and Proteoglycans” we describe in outline the common structural features of glycosaminoglycans and the characteristics of proteoglycans, including the intracellular proteoglycan, serglycin, cell-surface proteoglycans, like syndecans and glypicans, and the extracellular matrix proteoglycans, like aggrecan, perlecan, and small leucine-rich proteoglycans. The context in which the pharmaceutical uses of glycosaminoglycans and proteoglycans are presented in this special issue is given at the very end.
format Online
Article
Text
id pubmed-5874723
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-58747232018-04-02 Glycosaminoglycans and Proteoglycans Pomin, Vitor H. Mulloy, Barbara Pharmaceuticals (Basel) Editorial In this editorial to MDPI Pharmaceuticals special issue “Glycosaminoglycans and Proteoglycans” we describe in outline the common structural features of glycosaminoglycans and the characteristics of proteoglycans, including the intracellular proteoglycan, serglycin, cell-surface proteoglycans, like syndecans and glypicans, and the extracellular matrix proteoglycans, like aggrecan, perlecan, and small leucine-rich proteoglycans. The context in which the pharmaceutical uses of glycosaminoglycans and proteoglycans are presented in this special issue is given at the very end. MDPI 2018-02-27 /pmc/articles/PMC5874723/ /pubmed/29495527 http://dx.doi.org/10.3390/ph11010027 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Pomin, Vitor H.
Mulloy, Barbara
Glycosaminoglycans and Proteoglycans
title Glycosaminoglycans and Proteoglycans
title_full Glycosaminoglycans and Proteoglycans
title_fullStr Glycosaminoglycans and Proteoglycans
title_full_unstemmed Glycosaminoglycans and Proteoglycans
title_short Glycosaminoglycans and Proteoglycans
title_sort glycosaminoglycans and proteoglycans
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874723/
https://www.ncbi.nlm.nih.gov/pubmed/29495527
http://dx.doi.org/10.3390/ph11010027
work_keys_str_mv AT pominvitorh glycosaminoglycansandproteoglycans
AT mulloybarbara glycosaminoglycansandproteoglycans

Ejemplares similares